Steroids and IVIG Are Not Recommended for Rapidly Progressive Parkinsonism
Steroids and IVIG have no established role in treating rapidly progressive parkinsonism caused by neurodegenerative atypical parkinsonian disorders (such as PSP, CBD, or MSA), as these conditions are not immune-mediated and do not respond to immunotherapy. 1, 2, 3
Critical Distinction: Immune-Mediated vs. Neurodegenerative Causes
The key to answering this question lies in determining the underlying etiology of the rapidly progressive parkinsonism:
When Immunotherapy IS Indicated (Autoimmune Encephalitis)
- Steroids and IVIG are first-line treatments for autoimmune encephalitis, which can occasionally present with parkinsonian features 4
- High-dose corticosteroids (or IVIG or plasma exchange if steroids are contraindicated) should be initiated once infection is ruled out 4
- If no improvement occurs after initial treatment, adding IVIG or plasma exchange is recommended 4
- For severe presentations, combination therapy with steroids/IVIG or steroids/plasma exchange should be started from the beginning rather than sequentially 4
When Immunotherapy IS NOT Indicated (Atypical Parkinsonian Disorders)
- There are currently no disease-modifying treatments for progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), or multiple system atrophy (MSA) 2, 3
- These neurodegenerative conditions do not respond to immunotherapy because they are not immune-mediated 1, 5
- Recent clinical trials of various disease-modifying agents (rasagiline, rifampicin, tideglusib, davunetide) have all failed to show benefit 1, 5
- Management should focus on symptomatic support and optimizing quality of life through multidisciplinary care 2
Diagnostic Workup to Guide Treatment Decisions
Before considering immunotherapy, the following evaluation is essential:
- Brain MRI and/or EEG to look for focal or multifocal brain abnormalities suggestive of autoimmune encephalitis 4
- Lumbar puncture with CSF analysis including cell count, protein, glucose, oligoclonal bands, IgG index, and neuronal autoantibodies 4
- Serum neuronal autoantibodies testing 4
- Brain FDG-PET when clinical suspicion for autoimmune encephalitis is high but other studies are uninformative 4
Common Pitfalls to Avoid
- Do not empirically treat rapidly progressive parkinsonism with steroids or IVIG without evidence of an immune-mediated process 1, 2
- Levodopa may provide minimal, short-lived benefit in PSP and CBD, but poor levodopa response is actually part of diagnostic criteria for these conditions 2
- Avoid misclassifying neurodegenerative atypical parkinsonism as autoimmune encephalitis, as this leads to unnecessary immunotherapy with potential adverse effects and no benefit 1, 3
- If autoimmune encephalitis is confirmed, do not delay immunotherapy as early treatment improves outcomes 4